Previous Article | Next Article 
Molecular and Cellular Biology, December 2001, p. 7913-7922, Vol. 21, No. 23
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.23.7913-7922.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Methylation-Mediated Proviral Silencing Is
Associated with MeCP2 Recruitment and Localized Histone H3
Deacetylation
Matthew C.
Lorincz,1
Dirk
Schübeler,1 and
Mark
Groudine1,2,*
Division of Basic Sciences, Fred Hutchinson
Cancer Research Center, Seattle, Washington
98109,1 and Department of Radiation
Oncology, University of Washington School of Medicine, Seattle,
Washington 981952
Received 31 May 2001/Returned for modification 3 August
2001/Accepted 22 August 2001
 |
ABSTRACT |
The majority of 5-methylcytosine in mammalian DNA resides in
endogenous transposable elements and is associated with the
transcriptional silencing of these parasitic elements. Methylation also
plays an important role in the silencing of exogenous retroviruses. One
of the difficulties inherent in the study of proviral silencing is that
the sites in which proviruses randomly integrate influence the
probability of de novo methylation and expression. In order to compare
methylated and unmethylated proviruses at the same genomic site, we
used a recombinase-based targeting approach to introduce an in vitro
methylated or unmethylated Moloney murine leukemia-based provirus in
MEL cells. The methylated and unmethylated states are maintained in
vivo, with the exception of the initially methylated proviral enhancer,
which becomes demethylated in vivo. Although the enhancer is
unmethylated and remodeled, the methylated provirus is
transcriptionally silent. To further analyze the repressed state,
histone acetylation status was determined by chromatin immunoprecipitation (ChIP) analyses, which revealed that localized histone H3 but not histone H4 hyperacetylation is inversely correlated with proviral methylation density. Since members of the methyl-CpG binding domain (MBD) family of proteins recruit histone deacetylase activity, these proteins may play a role in proviral repression. Interestingly, only MBD3 and MeCP2 are expressed in MEL cells. ChIPs
with antibodies specific for these proteins revealed that only MeCP2
associates with the provirus in a methylation-dependent manner. Taken
together, our results suggest that MeCP2 recruitment to a methylated
provirus is sufficient for transcriptional silencing, despite the
presence of a remodeled enhancer.
 |
INTRODUCTION |
Cytosines in the context of a
CpG dinucleotide are frequently methylated in mammalian cells. Such
methylation is associated with the transcriptionally repressed state of
imprinted genes and endogenous retroelements. Although DNA methylation
can repress transcription by directly interfering with the binding of
sequence-specific transcription factors (27), the recent
discovery and biochemical characterization of the methyl-CpG binding
domain (MBD) family of proteins (24) have revealed that an
indirect mechanism of methylation-mediated repression also exists.
Several MBD proteins, including MBD1 (20), MBD2
(40), MBD3 (47), and the archetypal MeCP2
(38), are thought to play a role in transcriptional
repression. The discovery that MeCP2 interacts with a histone
deacetylase (HDAC)-containing core complex via recruitment of the Sin3A
corepressor (30, 39) has revealed that MeCP2 may function
in part by recruiting deacetylase activity to methylated DNA. The
recent finding that MBD2 interacts with the Mi-2/NuRD repressor
complex, of which MBD3 is an integral subunit (47, 52),
and the same HDAC-containing core complex suggests that alteration of
the local chromatin structure via recruitment of complexes containing
HDACs may be a general mechanism by which MBD proteins mediate
transcriptional repression. However, several observations suggest that
these proteins serve distinct functions in the cell: murine MBD3 binds
weakly (47) or not at all (24, 52) to
methylated DNA and, in contrast to MeCP2 and MBD2, does not colocalize
with the highly methylated major satellite DNA in murine cells
(24). Furthermore, transgenic studies have revealed that
while mbd3-null mice die in early embryogenesis and
mbd2-null mice are viable and fertile (25),
MeCP2-null mice show neurological abnormalities similar to those
observed in Rett syndrome (23). These differences suggest
that MBD proteins bind distinct loci and may repress a unique
complement of genes, yet little is known about the specific roles that
these proteins play in vivo.
Retrotransposons have accumulated during the course of vertebrate
evolution to the extent that such selfish DNA comprises over 45% of
the human genome (33). Long terminal repeat (LTR)-based transposable elements and other repetitive sequences interspersed in
the mammalian genome are typically transcriptionally silent and
methylated in adult somatic tissues (4). Given this
correlation and the fact that the majority of genomic 5-methylcytosine
is found in parasitic sequence elements, Bestor proposed that CpG methylation has evolved as a host defense system (4).
While this theory remains controversial, evidence has emerged
indicating that the transcription of endogenous retroviruses is indeed
constrained by methylation (48). Thus, the de novo
methylation machinery may preferentially target parasitic elements,
perhaps as a result of structural features characteristic of these
elements (5). Cytosine methylation also plays an important
role in the silencing of exogenous retroviruses in somatic tissues
(8). As a result, the propensity for therapeutic
retroviral vectors to become methylated and silenced in vivo remains
one of the major stumbling blocks to efficacious gene therapy treatment.
Previously, we showed that a Moloney murine leukemia virus
(MMuLV)-based retrovirus encoding the green fluorescent protein (GFP)
is rapidly de novo methylated and silenced in MEL cells (35). Because retroviruses integrate more or less randomly
in the genome, it is not possible to predict a priori the influence of
the local chromatin milieu, which may permit or inhibit expression. Thus, to determine the consequences of methylation for proviral expression and chromatin structure, it is desirable to compare unmethylated and methylated proviruses at the same genomic position. Recently, we established that Cre recombinase can be used to target in
vitro methylated DNA to defined genomic sites in MEL cells and that the
methylation introduced is stably maintained in vivo (45).
Here, we use this recombinase mediated-cassette exchange (RMCE)
(17) approach to generate either methylated or
unmethylated MMuLV provirus in two defined genomic sites in MEL cells.
Surprisingly, while these cells have the potential to efficiently
methylate proviral DNA (35), the unmethylated provirus
remained devoid of CpG methylation with long-term culture, while the
methylation state of the in vitro methylated provirus was substantially
maintained in vivo. Preservation of these distinct methylation states
permitted analysis of the influence of methylation on expression, de
novo methylation, chromatin remodeling, histone acetylation state, and
MBD protein binding. Using chromatin immunoprecipitation (ChIP), we
show that the methylated, silent provirus is associated with deacetylated histones and that MeCP2 is recruited to the provirus in a
methylation-dependent manner.
 |
MATERIALS AND METHODS |
Generation and in vitro methylation of the L1-MFGhGFP-1L
plasmid.
The MMuLV-based retroviral vector MFGhGFP (2,
35) was originally isolated as an
EcoRI-HindIII fragment including the complete
proviral genome flanked by 396 and 697 bp of mouse genomic sequences 5' and 3' of the retroviral genome, respectively
(15). To generate a construct for RMCE, MFGhGFP was
digested with EcoRI and HindIII and cloned
into the L1-1L cloning vector DpBlueKS(+)L1-PL-1L (sequence available
upon request) to generate L1-MFGhGFP-1L. In vitro methylation of this
construct with SssI methylase (New England Biolabs),
which methylates all CpGs, was performed as described elsewhere
(http://stke.sciencemag.org/cgi/content/full/OC_sigtrans;2001/83/pl1). To determine that the reaction was carried out to completion, following
organic extraction and ethanol precipitation, methylated DNA was
digested with the methylation-sensitive enzymes HpaII and
HhaI and visualized by electrophoresis on a 0.7% agarose
gel as described elsewhere
(http://stke.sciencemag.org/cgi/content/full/OC_sigtrans;2001/83/pl1).
Tissue culturing and gene targeting.
MEL 745 cells
(16) were maintained in growth medium (Dulbecco modified
Eagle medium, 10% bovine calf serum, 100 U of penicillin/ml, 0.05 mM
streptomycin, 2 mM glutamine) supplemented with 750 µg of hygromycin
(Roche)/ml in log phase for at least 2 weeks prior to transfection to
select cells expressing the HYTK (hygromycin B-phosphotransferase-thymidine kinase) fusion gene. Approximately 4 × 106 cells were electroporated in the
presence of 15 µg of cytomegalovirus enhancer-Cre expression
vector (45), 100 µg of sonicated salmon sperm DNA, and
25 µg of the L1-MFGhGFP-1L plasmid as previously described
(45). After 3 days in nonselective medium, the cultures were supplemented with 10 µM ganciclovir and cultured for 7 days to
select against HYTK-expressing cells. Ganciclovir-resistant cells were cloned by limiting dilution and screened for Cre-mediated exchange by Southern blotting. Greater than 80% of the clones analyzed
contained a cassette integrated in one of the two possible orientations.
Nuclease sensitivity analysis.
DNase I digestion of nuclei
was performed as described previously (18). DNase
I-digested genomic DNA was purified and digested with BamHI.
The GFP probe used for Southern hybridization was generated by
digestion of the MFG-hGFP plasmid with NcoI and
BamHI, yielding a restriction fragment including the 720-bp
hGFP gene.
Northern blot hybridization and RT-PCR analysis.
Northern
blot hybridization was conducted by standard procedures with 12 µg of
total RNA prepared with Trizol reagent (GibcoBRL) according to the
manufacturer's protocol and the GFP probe described above. For reverse
transcription (RT)-PCR, total RNA was isolated as described for
Northern analysis. SuperScript II (GibcoBRL) reverse transcriptase was
used for first-strand cDNA synthesis as described previously
(43). Primer pairs specific for MBD1 (plus-strand
[+str], CCTGGCTGGAAACGCCGAGAGTCC; minus-strand [
str], GTGAAGCTAGAGCTGTGGCAGTAGG), MBD2 (+str,
GATGGAAGAAGGAGGAAGTGATCC;
str,
CGTGGTTGTTCATTCATCCGCTGG), MBD3 (+str,
GGCGCTCCCGCAGGGCTGGGAAAG;
str,
CCTTGGGCAAGTCCATGGTCCTGAC), and MeCP2 (+str,
ATGGTAGCTGGGATGTTAGGGCTCAG;
str,
CAGTTCCTGGAGCTTTGGGAGATTTG) were used for RT-PCR (32 cycles), yielding products of 346, 366, 466, and 555 bp, respectively.
Bisulfite analysis.
Bisulfite conversion was carried out
with minor modifications using the protocol of Clark et al.
(11) as described previously (35). Briefly,
mixtures containing 5 µl of bisulfite-treated DNA (final volume, 50 µl) were subjected to 25 to 32 amplification cycles using a GeneAmp
PCR system 9700 (Perkin-Elmer) with denaturation at 94°C, annealing
at 49 to 56°C, and extension at 72°C. Nested or seminested
amplification was performed using 2 µl of product from the first
round in a 50-µl reaction volume. Primers were designed to favor the
amplification of bisulfite-converted DNA. If the template strand
included a CpG, degeneracy was incorporated in the primer at the
nucleotide position corresponding to the cytosine such that no bias for
amplification of the methylated template was introduced. Primers used
for the 5' LTR were as follows: bis+25+
(TAGGTTTGGTAAGTTAGTTTAAGTAAYGTT) with bis+1080
(TAAAAAAATAATAACAAACTAACCCRAAC) in the first round and
bis+25+ (TTGTAAGGTATGGAAAAATATATAATTG) with bis+665
(TAAATTACTAACCAACTTACCTCCCRATAA) in the second round. Primers used for the seminested junction reactions were as follows: +bis3LTR (TGATTGGTATAATGGGAAATTGATTTTGAT) with bis1Ldis2
(TTACRATTCCTAACCTTTTACTAACC) and bis1Ldis
(ACCRATTCATTAATACAACTAACACRAC) in the first and second rounds, respectively.
Flow cytometry and Western blot analysis.
For
fluorescence-activated cell sorting analysis, cells were harvested and
resuspended in staining medium (phosphate-buffered saline supplemented
with 3% calf serum) supplemented with 1 µg of propidium iodide/ml
for live/dead discrimination. Data were collected with a FACSCalibur
(Becton Dickinson) equipped with the standard fluorescein filter set.
Data for a minimum of 10,000 live cells were collected, and the
fluorescence distribution was determined with FlowJo software
(Treestar). For Western blot analysis, MEL and HeLa cell nuclear
extracts were generated as described by Dignam et al.
(14). Mouse brain nuclear extracts (Upstate Biotechnology)
were used as a positive control, where appropriate. Western blotting
was conducted according to the protocol provided by Santa Cruz
Biotechnology with a GFP monoclonal antibody (Clontech) or polyclonal
antibodies specific for MBD3 (Santa Cruz Biotechnology) or MeCP2
(Upstate Biotechnology). Chromatin used for Western blotting was
generated with and without isopycnic centrifugation (as described below) for MBD3 and MeCP2, respectively, and boiled for 10 min in the
presence of electrophoresis sample buffer (Santa Cruz Biotechnology) prior to loading on a denaturing acrylamide gel.
ChIPs.
To generate cross-linked chromatin for ChIPs with
antiacetylated histone antibodies, exponentially growing cells (2 × 108) were fixed with 1% formaldehyde at room
temperature for 3 min, and chromatin was purified as described
previously (44). Briefly, fixed cells were washed once in
buffer 1 (10 mM Tris [pH 8], 10 mM EDTA, 0.5 mM EGTA 0.25% Triton
X-100), washed twice in buffer 2 (10 mM Tris [pH 8], 1 mM EDTA, 0.5 mM EGTA, 0.2 M NaCl), and resuspended in buffer 3 (10 mM Tris [pH 8],
1 mM EDTA, 0.5 mM EGTA) prior to sonication. All buffers were
supplemented immediately prior to use with 10 mM sodium butyrate. After
sonication (four times for 30 s each time on ice; Fisher
Scientific sonic Dismembrator, highest setting), protein-DNA complexes
were purified by isopycnic (CsCl) centrifugation (41). The
DNA content of cross-linked chromatin was quantified using a Hoefer
Instruments fluorometer. Immunoprecipitations with purified chromatin
were conducted as described previously (44) using
polyclonal antibodies against all acetylated isoforms of histone H4
(AcH4) or against histone H3 acetylated at lysines 9 and 14 (AcH3)
(Upstate Biotechnology). A 1:1 mixture of protein A and G-Sepharose
beads (Amersham) was used for all immunoprecipitations. Washes
and reversal of the cross-link were conducted as described previously
(44). DNA fragments ranged in size from 0.3 to 1.0 kb.
For ChIPs with polyclonal antibodies specific for MeCP2 or MBD3, cells
were fixed for 30 min with formaldehyde as described above, washed once
in buffer 1, washed twice in buffer 2, resuspended in 2 ml of
immunoprecipitation buffer (40 mM Tris [pH 8], 4 mM EDTA, 300 mM
NaCl, 1% Triton X-100) supplemented with protease inhibitors [10 µg
of aprotonin/ml, 1 µg of pepstatin/ml, 1 µg of leupeptin/ml, and 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF)], and
sonicated as described above. Chromatin was centrifuged for 10 min
(12,000 × g) at 4oC to remove
debris, and 100 µl of supernatant was used for immunoprecipitation or
to prepare input DNA. Goat preimmune serum and rabbit immunoglobulin G
were used as controls for MBD3 and MeCP2 immunoprecipitations, respectively. Washes and reversal of the cross-link were conducted as
described above.
Quantitative PCR was performed with a Perkin-Elmer 9700 thermocycler
and 0.5 to 1.5 ng of reverse-cross-linked DNA from input
and
antibody-bound chromatin. Conditions for linear amplification
(see Fig.
2 and reference
44) were achieved for all reactions
using
27 to 29 cycles of amplification and a 60
oC
annealing temperature. Each 25-µl reaction mixture was supplemented
with 1 µCi of [

-
32P]dCTP (NEN). Primer
pairs for the proviral LTR (

9LTR+ST,
CATGTGAAAGACCCCACCTGTAG;
5LTR329

,
AATAAGGCACAGGGTCATTTCAGG) and the GFP gene (GFP1,
ACATGAAGCAGCACGACTTC;
GFP2, TGCTCAGGTAGTGGTTGTC)
are specific for the introduced cassette
and give product sizes of 364 and 377 bp, respectively. Control
primer pairs for the mouse amylase
gene (amy4 and amy6) and the
mouse

-major promoter
(mubmp1 and mubmp2) of the B-globin locus
(
44) give
products of 400 and 320 bp, respectively, permitting
duplex PCR with
the transgene primer sets. One-third of the reaction
product was loaded
on a 5% nondenaturing polyacrylamide gel and
subjected to
electrophoresis. Products were quantified with a
PhosphorImager and
ImageQuant software (Molecular Dynamics). To
determine the level of
protein enrichment at a given region in
the provirus, the ratio of the
two PCR products was calculated
for the antibody-bound fraction and
normalized to the ratio obtained
for the input
material.
 |
RESULTS |
Targeting of methylated and unmethylated proviral DNA to defined
genomic sites.
In order to study the mechanism of
methylation-mediated proviral silencing, we used a
Cre-loxP-based system, which allows for the introduction of
DNA constructs flanked by inverted loxP sites at specific
sites in the genome (Fig. 1A). This
method, RMCE (17), involves selection against thymidine
kinase (TK) expression from the preexisting cassette rather than for
expression from the introduced cassette. Thus, potentially
nonexpressing, methylated constructs can be introduced and clones can
be efficiently isolated for further analysis (45).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 1.
Principle and application of Cre-mediated
targeting of methylated and unmethylated proviruses at a defined
genomic site. (A) A cell line containing a stably integrated L1-HYTK-1L
gene flanked by inverted loxP sites (black triangles) is
transfected with the proviral construct L1-MFGhGFP-1L (also flanked by
inverted loxP sites) together with a Cre recombinase
expression plasmid. Recombination between the loxP sites
in the two constructs results in exchange of the cassettes and loss of
the TK-negative selectable marker. Alternatively, recombination between
the inverted loxP sites on the same DNA molecule occurs,
resulting in the inversion of the intervening DNA. Cells that have
undergone the latter recombination event still express the HYTK gene
and thus can be selected against with ganciclovir, allowing the
isolation of cells that have undergone the targeting reaction. Note
that selection is not dependent on the expression of the introduced
cassette. hGFP, humanized GFP. (B) The L1-MFGhGFP-1L construct,
containing the MFGhGFP retroviral vector, was methylated with
SssI methylase and digested with the
methylation-sensitive restriction (Restric) enzyme
HpaII and its insensitive isoschizomer
MspI to establish that the reaction was carried to
completion. Methylated DNA was introduced into RL5 or RL6 L1-HYTK-1L
MEL cells, and ganciclovir-resistant clones were generated by limiting
dilution. Clones with an unmethylated L1-MFGhGFP-1L cassette were also
generated. (C) Genomic DNA was isolated from RL5 clones after
ganciclovir selection and digested with BamHI, which
cuts only at the 3' end of the GFP gene and thus generates junction
fragments of different sizes depending on the orientation of the
insertion. Southern blot analysis using a GFP probe to confirm the
fidelity of targeting reveals that the majority of clones contain the
provirus preferentially integrated in one of the two possible
orientations. Marker lanes (M) are included on each gel.
|
|
L1-MFGhGFP-1L, a construct containing the retroviral vector MFGhGFP
(
2) flanked by inverted
loxP sites, was
methylated
in vitro with the bacterial methyltransferase
SssI, yielding a
cassette methylated at all CpGs (Fig.
1B).
The previously characterized
MEL cell lines RL5 and RL6
(
16), which harbor a stably integrated
HYTK cassette
flanked by inverted
loxP sites, were transfected
with
methylated or control, unmethylated L1-MFGhGFP-1L DNA in
combination
with a Cre recombinase expression plasmid. Cre-mediated
recombination
of this construct, which includes the complete proviral
genome and
flanking mouse genomic DNA, yields a single integrated
provirus which
appears topologically as it would following conventional
proviral
integration. After ganciclovir selection, clones were
isolated and
analyzed by Southern blot hybridization for the presence
and genomic
orientation of the L1-MFGhGFP-1L cassette. As expected,
the majority of
TK-resistant RL5 and RL6 clones contained the
provirus integrated in
one of the two possible genomic orientations
(Fig.
1C).
The proviral transcription state depends upon the initial density
of methylation.
From both the RL5 and the RL6 cell lines, at least
two clones with unmethylated or methylated cassettes in each
orientation were expanded for further analysis. The expression state of
these clones was determined by flow cytometry, and representative
orientation-matched RL5 clones M8 (M, methylated) and U12 (U,
unmethylated) are shown in Fig. 2A. All
MEL clones with an unmethylated cassette show stable expression in
greater than 95% of cells (data not shown). In contrast, all
SssI-methylated clones show fluorescence intensity comparable to that seen in control RL5 MEL cells. The absence of GFP in
the methylated clone was confirmed by Western blotting with an antibody
raised against GFP (Fig. 2B), and Northern hybridization analysis
revealed that expression is blocked at the level of transcription (Fig.
2C). The active and repressed transcription states of the unmethylated
and methylated clones, respectively, suggest that the methylation state
generated in vitro is maintained in vivo upon genomic integration of
the provirus and that de novo methylation of the unmethylated cassette
does not occur. Comparable results were found at the RL6 integration
site (data not shown).

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 2.
Methylation of the MFGhGFP provirus is necessary and
sufficient for proviral silencing. (A) Representative in vitro
methylated (M8) and unmethylated (U12) L1-MFGhGFP-1L clones (black
histograms) in the same genomic orientation and control RL5 cells (gray
histograms) were analyzed by flow cytometry at day 46 posttransfection.
Greater than 97% of clone U12 cells show GFP expression, while greater
than 99% of M8 cells show low to undetectable levels of expression.
(B) The lack of GFP expression was confirmed by Western blot analysis
using an anti-GFP antibody. This reagent also recognizes a nonspecific
protein (N), which serves as an internal control for protein loading.
(C) To confirm that repression acted at the level of transcription,
Northern blotting was performed using equal amounts of total RNA
isolated 74 days after electroporation. As expected, the unmethylated
clone expresses both spliced (S) and unspliced (U) isoforms, while the
methylated clone and RL5 MEL parent cell line show no detectable
signal.
|
|
The methylation state is maintained in vivo, with the exception of
the 5' LTR enhancer, which is preferentially demethylated.
Preliminary analysis by Southern hybridization of genomic DNA isolated
from several L1-MFGhGFP-1L MEL clones 21 days after electroporation
revealed that the initially unmethylated provirus is not methylated de
novo, while the initially methylated cassette becomes demethylated,
specifically in the 5' LTR enhancer (data not shown). As similar
results were found for both integration sites, we focused on the
methylated and unmethylated RL5 clones, M8 and U12, respectively.
The PCR-based bisulfite sequencing method (
11) was used to
determine the methylation state of all CpGs within several regions
of
the provirus, including the plasmid-L1-proviral junction upstream
of
the 5' LTR, the 5' LTR itself, the GAG region (data not shown),
and the
GFP gene (Fig.
3A). Consistent with the
Southern hybridization
data, unmethylated clone U12 remains virtually
devoid of methylation
across the introduced cassette (Fig.
3B to D).
Methylated clone
M8, in contrast, remains methylated throughout the
provirus, with
the exception of the CpGs in the enhancer region, which
are consistently
demethylated (Fig.
3C), and several CpGs in the
promoter and GFP
gene, which are sporadically demethylated (Fig.
3C and
D). Interestingly,
regardless of the methylation status of the
introduced provirus,
no methylation was detected in the region upstream
of the introduced
cassette (Fig.
3B), suggesting that spreading of
methylation does
not occur at this integration site. The stability of
two distinct
methylation states of a provirus integrated at the same
genomic
site in the same orientation allowed us to study the properties
of proviral methylation in the absence of position effects.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 3.
Detailed methylation mapping of methylated and
unmethylated proviral clones. Genomic DNA isolated 56 days after
electroporation was bisulfite converted, and the regions of interest
were PCR amplified, subcloned, and sequenced (see Materials and
Methods). (A) The regions amplified, including the junction
region, the 5' LTR, and the GFP gene (thick black lines), are shown
relative to the L1-MFGhGFP-1L map. (B to D) Open and filled ovals
correspond to CpGs and methylated CpGs, respectively. For each
amplified region, at least six molecules from clones M8 and U12 were
sequenced. Bisulfite sequencing of the junction region (B), the 5' LTR
(C), and the GFP gene (D) reveals the absence of methylation in the
initially unmethylated clone U12 and the maintenance of methylation,
with the exception of the enhancer region, in the methylated clone M8.
PBS, primer binding site.
|
|
Remodeling of the LTR enhancer is not influenced by the proviral
methylation state.
Having shown that demethylation of the enhancer
region occurs independently of the transcription state, we next sought
to study the chromatin structure of the proviral 5' LTR by assaying for
the formation of DNase I-hypersensitive sites (HSs) previously described for this region (46). Nuclei isolated from M8
and U12 cells were incubated with increasing amounts of DNase I, and purified genomic DNA was analyzed by Southern blot hybridization after
digestion with BamHI (Fig. 4).
While the promoter HS forms only in the unmethylated clone, the
enhancer HS forms regardless of the methylation state of flanking DNA,
indicating that recruitment of nuclear factors to the enhancer occurs
independently of transcription or methylation state at the promoter and
coding region.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 4.
Dependence of LTR enhancer and promoter remodeling on
methylation state. Nuclei were isolated from RL5 clones M8 and U12 and
digested with increasing concentrations of DNase I. Subsequently,
genomic DNA was isolated, digested with BamHI, and
subjected to Southern hybridization with a GFP probe. Predicted HSs at
the proviral enhancer (enh) and promoter (pro), as well as a genomic
site (g) upstream of the introduced cassette, are labeled with arrows.
A sample with no DNase I added (lane 0) is also shown. Note the absence
of the promoter HS in the methylated clone. hGFP, humanized
GFP.
|
|
Proviral methylation correlates with histone H3 deacetylation.
We used ChIPs to determine if histones associated with the methylated
provirus are hypoacetylated relative to the unmethylated provirus.
Primer pairs specific for the proviral 5' LTR (which includes the
direct repeat enhancer) and GFP gene (Fig.
5A), in addition to the endogenous
amylase 2.1y gene, were generated, and PCR conditions were established
to ensure linear amplification (Fig. 5B). Formaldehyde-cross-linked
chromatin from clones M8 and U12 was immunoprecipitated with antisera
specific for AcH3 or AcH4, and antibody-bound DNA was eluted and
analyzed by duplex PCR using either of the proviral primer pairs in
combination with the amylase primer pair. The latter serves as a
control in MEL cells, as this gene is in a closed chromatin
conformation characterized by relative hypoacetylation for histones H3
and H4 (44). The ratio of the two PCR products was
determined for the antibody-bound fraction and normalized to the ratio
obtained from the input chromatin.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 5.
Histone acetylation is dependent on proviral methylation
status. (A) A map of the L1-MFGhGFP-1L provirus is shown with the
locations of the primer pairs used to amplify either the 5' LTR or the
GFP gene. SA, splice acceptor; SD, splice donor. (B) Amplification of
titrated input DNA using these primer pairs and a control primer pair
specific for the endogenous mouse amylase 2.1y gene is linear under the
conditions used for duplex PCR (see Materials and Methods).
Formaldehyde-cross-linked chromatin was purified by isopycnic
centrifugation and immunoprecipitated with antibodies recognizing AcH4
or AcH3. After reversal of the cross-link, duplex PCR was performed for
the input and antibody-bound chromatin fractions (equivalent to
approximately 1 to 2 ng of DNA) with the amylase 2.1y primer pair in
combination with either the 5' LTR or the GFP gene primer pair in the
presence of radiolabeled deoxycytidine. (C) The PCR products from the
input (I) and antibody-bound DNA (H3 and H4) were resolved by
electrophoresis on a nondenaturing acrylamide gel. Amy, amylase 2.1y.
(D) To determine the enrichment of proviral sequences relative to the
nonexpressed, hypoacetylated amylase gene, products from three
independent duplex amplifications were quantified by PhosphorImager
analysis. The ratio of the two PCR products was determined for the
antibody-bound fraction and normalized to the ratio obtained from the
input material prior to immunoprecipitation. The mean and standard
error of the mean are plotted. The x axis is set at 1, which reflects no enrichment relative to the amylase 2.1y gene.
|
|
A representative set of duplex PCRs is shown in Fig.
5C, and a summary
of three independent amplifications is shown in Fig.
5D. The
acetylation state of histone H4 was not influenced by
the presence of
methylation. In contrast, unmethylated clone U12
shows an 18-fold
enrichment of AcH3 relative to amylase within
the LTR, versus only
9-fold for methylated clone M8, indicating
that H3 is relatively
hypoacetylated in the methylated clone in
this region. Similarly, U12
shows a 23-fold enrichment of AcH3
within the GFP gene, while M8 shows
only a 4-fold enrichment in
this region. Thus, relative to the
methylated clone, the unmethylated
clone shows two- and fivefold
greater levels of enrichment of
AcH3 in the LTR and GFP regions,
respectively, demonstrating that
the methylation state of the provirus
strongly influences the
acetylation state of histone
H3.
Expression of MBD proteins in MEL cells.
The association of
hypoacetylated histone H3 with the silent proviral reporter suggests
that HDAC activity plays a role in methylation-mediated repression.
Given that MeCP2, MBD2, and MBD3 all interact with complexes containing
HDAC1 and/or HDAC2, this result is not informative with respect to
which of these proteins, if any, are bound to the methylated provirus.
Although MBD proteins are ubiquitously expressed in somatic tissues
(24), RT-PCR with primer pairs specific for MBD1, MBD2,
MBD3, and MeCP2 revealed that only MBD3 and MeCP2 are expressed in MEL
cells (Fig. 6A). These results were
confirmed by Western blotting using antisera specific for each MBD
protein (Fig. 6B and data not shown). Simultaneous analysis of
reverse-cross-linked chromatin preparations revealed that MeCP2 and
MBD3 are detectable in formaldehyde-cross-linked chromatin.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 6.
MeCP2 and MBD3 are expressed in MEL cells and are
detectable in chromatin preparations. (A) mRNAs from MEL cells and
mouse brain as a positive control were reverse transcribed, and the
cDNA generated was used as a template for PCR with primers specific for
MBD1, MBD2, MBD3, and MeCP2. Only MBD3 and MeCP2 are expressed in MEL
cells. RT, without reverse transcriptase. (B) Western blot
analyses were conducted with antibodies specific for MeCP2 and MBD3.
Nuclear extracts were prepared from HeLa, MEL 745A, and MEL RL5 cells,
and 10 to 20 µg of protein was loaded per lane. Crude (for MeCP2) or
purified (for MBD3) chromatin preparations (see Materials and Methods)
were also generated and subjected to electrophoresis in parallel with
the nuclear extracts.
|
|
MeCP2 is associated with the methylated provirus.
A series of
ChIP experiments using MBD3 or MeCP2 antisera were carried out to
establish which, if either, of these proteins is recruited to the
methylated provirus in vivo. Chromatin from clones M8 and U12 was
generated without isopycnic centrifugation (see Materials and Methods),
and the immunoprecipitated material was subjected to duplex PCR. The
transcriptionally active (44) and presumably unmethylated
endogenous
-major globin gene promoter was used, rather than the
silent amylase gene, as it is less likely to be associated with MBD
proteins. The level of enrichment of MBD3 was low to undetectable,
regardless of the methylation state (Fig.
7). Similar results were found when
chromatin purified by isopycnic centrifugation was used (data not
shown). The absence of enrichment is not likely to be due to
insufficient cross-linking, as MBD3 can be detected in purified
cross-linked chromatin (Fig. 6B). In contrast, while clone U12 shows no
enrichment for MeCP2 relative to the
-major promoter, clone M8 is
significantly enriched for MeCP2 in both the proviral 5' LTR and the
GFP gene (Fig. 7B), suggesting that methylation is necessary and
sufficient for the recruitment of MeCP2 in vivo. Repetition of the
MeCP2 and MBD3 immunoprecipitations with independently generated
chromatin confirmed these results (Fig. 7C). Thus, MeCP2 is apparently
the only known MBD protein targeted to the methylated provirus in MEL
cells.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 7.
MeCP2 is recruited to the methylated provirus.
Formaldehyde-cross-linked chromatin was prepared from MEL clones M8 and
U12 without isopycnic centrifugation (as described in Materials and
Methods). (A) Chromatin was immunoprecipitated with goat preimmune
serum or antibodies specific for AcH3 (H3) or MBD3. Duplex PCR was
conducted with the 5' LTR or GFP gene primers described in Fig. 5, in
combination with a control primer pair specific for the actively
transcribed -major promoter region ( Maj) of the endogenous
-globin locus. A representative acrylamide gel is shown, along with
the levels of enrichment, as measured by PhosphorImager analysis,
relative to the input (I) sample. The goat-derived MBD3 antibody shows
no significant enrichment relative to the control goat serum. In
contrast, concurrent immunoprecipitation with the AcH3 antibody shows a
7- to 10-fold difference in abundance between the unmethylated and the
methylated proviruses, confirming the fidelity of the chromatin
preparation. (B) Immunoprecipitation with control rabbit immunoglobulin
G or antibodies specific for AcH3 (H3) or MeCP2 reveals that MeCP2 is
significantly enriched in the 5' LTR and the GFP gene of the methylated
clone. (C) Quantification of duplex PCR products from two chromatin
preparations (three independent MeCP2 or MBD3 immunoprecipitations)
confirms these results. The mean and standard error of the mean for the
enrichment are plotted (see the text). The x axis is set
at 1, which reflects no enrichment.
|
|
 |
DISCUSSION |
Genomic targeting of methylated provirus.
Random integration
in the host genome is an integral component of the retroviral life
cycle. Analysis of the mechanism(s) of methylation-mediated proviral
silencing has been complicated by the fact that the chromatin structure
of the integration site influences the level and stability of
expression, the propensity for de novo methylation, and the complement
of associated DNA binding factors (13). To avoid the
inherent complications associated with such position effects, we
modified the Cre recombinase-based targeting system, RMCE
(17), to target in vitro methylated DNA into the genome
(45;
http://stke.sciencemag.org/cgi /content/full/OC_sigtrans;2001/83/pl1). Here, we introduced an MMuLV-based provirus, unmethylated or
methylated in vitro, into two defined genomic sites in MEL cells. With
the striking exception of the proviral enhancer, CpG methylation is stably maintained in vivo, while at the same integration site, an
initially unmethylated provirus remains devoid of methylation for at
least 2 months in culture. Given that 100% of the cells in clone U12
express GFP for at least 6 months in cultures (data not shown), we
infer that the virus will remain unmethylated indefinitely at this
site. In contrast, we found previously that this retroviral vector is
particularly prone to de novo methylation when introduced by infection
in MEL 745 cells, with the majority of initially GFP-positive clones
being silenced and presumably methylated after 1 month in culture
(35). The absence of de novo methylation of the provirus
integrated at RL5 suggests that the integration site itself is somehow
protected from de novo methyltransferase activity. Alternatively, the
difference in susceptibility to de novo methylation may be due to the
fact that the structures of the integration intermediates differ
between viral integrase-mediated and Cre-mediated rearrangements
(5). However, a comparison of single-copy proviruses
introduced by transfection versus infection did not reveal a difference
in the rate of silencing (3). Regardless, the generation
of stable, complementary proviral methylation states at a defined
genomic site permitted us to study the influence of preexisting
methylation on de novo methylation, chromatin structure, and MBD
protein binding.
Dense CpG methylation is not sufficient to promote methylation
spreading.
While the methylated provirus introduced at RL5
remained methylated and transcriptionally inactive after long-term
culture, CpGs in the region flanking the introduced cassette were never methylated, indicating that a methylated provirus does not necessarily act as a focus for the initiation of methylation spreading, as has been
previously reported (29, 32). The absence of methylation spreading is not a peculiarity of proviral constructs, as methylation spreading from a methylated
-globin reporter construct integrated at
this site was not observed either (45). Nor is the absence of methylation spreading due to the presence of the LTR enhancer element, since no methylation was detected in the flanking DNA of a
methylated construct from which the 5' LTR enhancer region was deleted
(data not shown). Taken together, these results suggest that the
integration site, rather than features of the heterologous element
itself, may be the dominant factor in determining the probability of de
novo methylation.
The LTR enhancer is demethylated and remodeled regardless of the
transcription state.
In the majority of clones analyzed, the two
initially premethylated CpGs in the proviral enhancer are demethylated,
results consistent with those previously reported for germ
line-transmitted retroviral genomes (28) and for MEL
cell clones infected with the MFGhGFP vector (35).
These CpG sites overlap with a putative NF-1 binding site present in
each of the direct repeats (21), raising the possibility
that the enhancer may contain a binding site(s) for a complex with
intrinsic demethylating activity. Consistent with this hypothesis, the
DNase I-HS in the 5' LTR enhancer region (46) still forms.
Interestingly, Zhu et al. (53) recently showed that the
hormone receptor RXR
interacts with a G/T-mismatched 5-methylcytosine DNA glycosylase which demethylates CpGs around the
receptor DNA binding site in the absence of a ligand and regardless of
the transcription state. The demethylated CpGs within the proviral tandem repeat enhancer are located within 20 bp of a
glucocorticoid-responsive element site, raising the possibility that in
MEL cells, the enhancer may be bound by endogenous hormone receptor
complexes which demethylate adjacent CpGs.
Alternatively, transcription factor binding may itself be sufficient to
trigger the demethylation of nearby methylated CpGs
(
26).
In support of the latter model, demethylation of the HS2
enhancer
element from the

-globin locus in another methylated
construct
introduced in RL5 was also observed (
45). Nevertheless,
the transcriptional activators bound to the HS2 or LTR enhancers
are
insufficient to overcome methylation-mediated repression,
suggesting
that dense methylation of the promoter and downstream
regions in some
way neutralizes enhancer
function.
The methylated provirus is hypoacetylated for histone H3.
The
modification of histone tails by acetylation is strongly associated
with transcriptional competence (10). Conversely, histone
deacetylation is associated with transcriptional silencing, and a
number of repressor proteins have recently been shown to interact with
HDAC complexes (42). In vitro and in vivo experiments have
revealed that several MBD proteins, including MeCP2 (30, 39), MBD2 (52), and MBD3 (47, 52), are
associated with repressor complexes that include HDACs, implicating a
role for local histone deacetylation in methylation-mediated silencing (6). The ChIP experiments presented here revealed that
histone H3 associated with the GFP gene in particular and the LTR to a lesser extent is hypoacetylated in the methylated provirus relative to
the unmethylated provirus. In contrast, no difference in acetylation was observed for histone H4. Considering that the LTR is demethylated in vivo, the H3 acetylation state correlates closely with the location
of methylated CpGs in the provirus. These results are consistent with a
previous analysis of a
-globin reporter construct in MEL cells
(44). However, consistent with previous results obtained
with the MFGhGFP retroviral vector introduced by infection (35), treatment with the HDAC inhibitor trichostatin A
(TSA) failed to induce GFP expression from the methylated
provirus in RL5 (data not shown).
The failure of TSA-mediated activation of densely methylated genes may
be the rule rather than the exception (
7,
36),
suggesting
that an HDAC1- or HDAC2-independent mechanism of transcriptional
repression plays a role in maintaining the silent state of methylated
genes. Deacetylated histone H3 associated with methylated DNA
may be
marked by additional covalent modifications (
10). For
example, methylation of deacetylated lysine 9 in the H3 histone
tail
might render it refractory to histone acetyltransferase activity,
thus
consolidating the silent state (
37). Interestingly,
treatment
of the repressed provirus with TSA revealed no change in the
histone
H3 acetylation state of the LTR or the GFP gene (data not
shown),
results consistent with those of Coffee et al.
(
12) and supportive
of the hypothesis that the inhibition
of HDAC activity is insufficient
for the acetylation of histones in
densely methylated
DNA.
CpG methylation is necessary and sufficient for the recruitment of
MeCP2 to the MMuLV provirus.
While the repressor complexes with
which several of the MBD proteins interact have been characterized,
little is known about the sequences to which these proteins are
recruited in vivo. Recently, Magdinier and Wolffe (36)
showed that MBD2 is recruited in a methylation-dependent manner to the
p14/p16 locus in human neoplastic cells. Using a model system for
proviral methylation, we showed that MeCP2 is recruited in vivo to a
proviral construct in a methylation-dependent manner. In contrast, we
did not detect binding of MBD3 to the provirus. The latter result is
not surprising, given that purified murine MBD3 binds weakly
(47) or not at all (24, 52) to methylated
oligonucleotides in gel shift analyses. In fact, methylation-dependent recruitment of the NuRD complex, of which MBD3 is an integral component, depends upon the presence of MBD2 (52). As MBD2
is not expressed in MEL cells, recruitment of the Mi-2/NuRD complex to
DNA is presumably dependent upon its interaction with other DNA binding
proteins (42). Since MBD1 is also not expressed in MEL
cells, MeCP2 seems to be the only known MBD protein associated with the
silent, methylated provirus. While we observed hypoacetylation of
histone H3 but not histone H4 associated with the methylated provirus,
a lack of functional MeCP2 was recently shown to result in
hyperacetylation of H4, as measured in a bulk assay for histone acetylation (49). In contrast, Gregory et al. reported
that MeCP2 is associated exclusively with the methylated maternal
allele of the imprinted gene U2af1-rs1 (22),
which is deacetylated at histone H3 exclusively, results entirely
consistent with our own. Thus, the influence of MeCP2 on the
acetylation of specific histones may depend on the locus at which the
MeCP2 protein is bound.
It has been hypothesized that the activation of endogenous
retroelements may disrupt normal patterns of tissue-specific gene
expression (
50). Given that Rett syndrome is linked to
mutations
in the MeCP2 gene (
1), it is tempting to
speculate that the
loss of MeCP2 function results in the activation of
endogenous
retroelements, which in turn disrupt the transcription of
neuronal
genes. The recent generation of MeCP2-null mice (
9,
23) should
allow for the detection of aberrant expression of
both retroelements
and endogenous genes in murine
tissues.
What role might MeCP2 play in repressing proviral transcription, given
that the 5' LTR enhancer is demethylated? In vitro
experiments with
MeCP2-Gal4 fusions show that this MBD protein
is capable of repressing
transcription when positioned over 400
bp from the transcriptional
start site (
38). Although the mechanism
of long-range
repression remains to be determined, Kaludov and
Wolffe observed a
direct interaction between MeCP2 and TFIIB,
a component of the basal
transcription machinery, suggesting that
MeCP2 may directly prevent
components of RNA polymerase from functioning
during assembly of the
preinitiation complex (
31). This alternative
mechanism of
repression may also explain why the inhibition of
HDAC activity fails
to induce proviral expression. In support
of this theory, using
MeCP2-Gal4 fusions and a Gal4-simian virus
40 reporter construct to
mimic methylation-mediated recruitment
of the MBD protein, Yu et al.
recently showed that MeCP2-mediated
repression is refractory to TSA
induction (
51). Taken together,
these results suggest that
MeCP2 is capable of repressing transcription
at a distance and
independent of the HDAC activity associated
with the Sin3A
complex.
MeCP2 is associated with pericentromeric heterochromatin in MEL cells
(data not shown), as has been observed previously in
other cell types
(
34). While the predominantly centromeric staining
of
MeCP2 does not exclude its presence in other parts of the interphase
nucleus, it is possible that the densely methylated provirus
colocalizes
in an MeCP2-dependent manner with pericentromeric
heterochromatin.
Recruitment to this nuclear compartment has been shown
to correlate
with transcriptional repression (
19) and may
represent a general
mechanism by which silencing of retroelements is
stably maintained.
The targeting system described here may be useful in
determining
the influence of DNA methylation on nuclear localization
and in
further defining the biochemical characteristics that
distinguish
the methylated and unmethylated states of the
provirus.
 |
ACKNOWLEDGMENTS |
This work was supported by NIH fellowship GM 19767/01to M.C.L., a
fellowship from the Rett Syndrome Research Foundation to D.S., and NIH
grants DK44746 and HL57620 to M.G.
We thank M. Bender for mouse brain cDNA; Eric Bouhassira and the
members of the Groudine laboratory for suggestions; Claire Francastel
and Tomoyuki Sawado for comments on the manuscript; and Joan Hamilton,
David Scalzo, Jennifer Stout, and Urszula Maliszewski for technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Fred Hutchinson
Cancer Research Center, 1100 Fairview Ave. N, A3-025, Seattle, WA
98109. Phone: (206) 667-4497. Fax: (206) 667-5894. E-mail:
markg{at}fhcrc.org.
 |
REFERENCES |
| 1.
|
Amir, R. E.,
I. B. Van den Veyver,
M. Wan,
C. Q. Tran,
U. Francke, and H. Y. Zoghbi.
1999.
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
Nat. Genet.
23:185-188[CrossRef][Medline].
|
| 2.
|
Anderson, M. T.,
I. M. Tjioe,
M. C. Lorincz,
D. R. Parks,
L. A. Herzenberg,
G. P. Nolan, and L. A. Herzenberg.
1996.
Simultaneous fluorescence-activated cell sorter analysis of two distinct transcriptional elements within a single cell using engineered green fluorescent proteins.
Proc. Natl. Acad. Sci. USA
93:8508-8511[Abstract/Free Full Text].
|
| 3.
|
Baer, A.,
D. Schübeler, and J. Bode.
2000.
Transcriptional properties of genomic transgene integration sites marked by electroporation or retroviral infection.
Biochemistry
39:7041-7049[CrossRef][Medline].
|
| 4.
|
Bestor, T. H.
1998.
The host defence function of genomic methylation patterns.
Novartis Found. Symp.
214:187-195[Medline].
|
| 5.
|
Bestor, T. H., and B. Tycko.
1996.
Creation of genomic methylation patterns.
Nat. Genet.
12:363-367[CrossRef][Medline].
|
| 6.
|
Bird, A. P., and A. P. Wolffe.
1999.
Methylation-induced repression belts, braces, and chromatin.
Cell
99:451-454[CrossRef][Medline].
|
| 7.
|
Cameron, E. E.,
K. E. Bachman,
S. Myohanen,
J. G. Herman, and S. B. Baylin.
1999.
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Nat. Genet.
21:103-107[CrossRef][Medline].
|
| 8.
|
Challita, P. M., and D. B. Kohn.
1994.
Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.
Proc. Natl. Acad. Sci. USA
91:2567-2571[Abstract/Free Full Text].
|
| 9.
|
Chen, R. Z.,
S. Akbarian,
M. Tudor, and R. Jaenisch.
2001.
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
Nat. Genet.
27:327-331[CrossRef][Medline].
|
| 10.
|
Cheung, P.,
C. D. Allis, and P. Sassone-Corsi.
2000.
Signaling to chromatin through histone modifications.
Cell
103:263-271[CrossRef][Medline].
|
| 11.
|
Clark, S. J.,
J. Harrison,
C. L. Paul, and M. Frommer.
1994.
High sensitivity mapping of methylated cytosines.
Nucleic Acids Res.
22:2990-2997[Abstract/Free Full Text].
|
| 12.
|
Coffee, B.,
F. Zhang,
S. T. Warren, and D. Reines.
1999.
Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.
Nat. Genet.
22:98-101[CrossRef][Medline].
|
| 13.
|
Conklin, K. F., and M. Groudine.
1986.
Varied interactions between proviruses and adjacent host chromatin.
Mol. Cell. Biol.
6:3999-4007[Abstract/Free Full Text].
|
| 14.
|
Dignam, J. D.,
R. M. Lebovitz, and R. G. Roeder.
1983.
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
Nucleic Acids Res.
11:1475-1489[Abstract/Free Full Text].
|
| 15.
|
Dranoff, G.,
E. Jaffee,
A. Lazenby,
P. Golumbek,
H. Levitsky,
K. Brose,
V. Jackson,
H. Hamada,
D. Pardoll, and R. C. Mulligan.
1993.
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
Proc. Natl. Acad. Sci. USA
90:3539-3543[Abstract/Free Full Text].
|
| 16.
|
Feng, Y. Q.,
M. C. Lorincz,
S. Fiering,
J. M. Greally, and E. E. Bouhassira.
2001.
Position effects are influenced by the orientation of a transgene with respect to flanking chromatin.
Mol. Cell. Biol.
21:298-309[Abstract/Free Full Text].
|
| 17.
|
Feng, Y. Q.,
J. Seibler,
R. Alami,
A. Eisen,
K. A. Westerman,
P. Leboulch,
S. Fiering, and E. E. Bouhassira.
1999.
Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange.
J. Mol. Biol.
292:779-785[CrossRef][Medline].
|
| 18.
|
Forrester, W. C.,
E. Epner,
M. C. Driscoll,
T. Enver,
M. Brice,
T. Papayannopoulou, and M. Groudine.
1990.
A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus.
Genes Dev.
4:1637-1649[Abstract/Free Full Text].
|
| 19.
|
Francastel, C.,
D. Schubeler,
D. I. Martin, and M. Groudine.
2000.
Nuclear compartmentalization and gene activity.
Nat. Rev. Mol. Cell. Biol.
1:137-143[CrossRef][Medline].
|
| 20.
|
Fujita, N.,
S. Takebayashi,
K. Okumura,
S. Kudo,
T. Chiba,
H. Saya, and M. Nakao.
1999.
Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms.
Mol. Cell. Biol.
19:6415-6426[Abstract/Free Full Text].
|
| 21.
|
Granger, S. W., and H. Fan.
1998.
In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
J. Virol.
72:8961-8970[Abstract/Free Full Text].
|
| 22.
|
Gregory, R. I.,
T. E. Randall,
C. A. Johnson,
S. Khosla,
I. Hatada,
L. P. O'Neill,
B. M. Turner, and R. Feil.
2001.
DNA methylation is linked to deacetylation of histone h3, but not h4, on the imprinted genes snrpn and u2af1-rs1.
Mol. Cell. Biol.
21:5426-5436[Abstract/Free Full Text].
|
| 23.
|
Guy, J.,
B. Hendrich,
M. Holmes,
J. E. Martin, and A. Bird.
2001.
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.
Nat. Genet.
27:322-326[CrossRef][Medline].
|
| 24.
|
Hendrich, B., and A. Bird.
1998.
Identification and characterization of a family of mammalian methyl-CpG binding proteins.
Mol. Cell. Biol.
18:6538-6547[Abstract/Free Full Text].
|
| 25.
|
Hendrich, B.,
J. Guy,
B. Ramsahoye,
V. A. Wilson, and A. Bird.
2001.
Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development.
Genes Dev.
15:710-723[Abstract/Free Full Text].
|
| 26.
|
Hsieh, C. L.
2000.
Dynamics of DNA methylation pattern.
Curr. Opin. Genet. Dev.
10:224-228[CrossRef][Medline].
|
| 27.
|
Iguchi-Ariga, S. M., and W. Schaffner.
1989.
CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation.
Genes Dev.
3:612-619[Abstract/Free Full Text].
|
| 28.
|
Jahner, D., and R. Jaenisch.
1985.
Chromosomal position and specific demethylation in enhancer sequences of germ line-transmitted retroviral genomes during mouse development.
Mol. Cell. Biol.
5:2212-2220[Abstract/Free Full Text].
|
| 29.
|
Jahner, D., and R. Jaenisch.
1985.
Retrovirus-induced de novo methylation of flanking host sequences correlates with gene inactivity.
Nature
315:594-597[CrossRef][Medline].
|
| 30.
|
Jones, P. L.,
G. J. Veenstra,
P. A. Wade,
D. Vermaak,
S. U. Kass,
N. Landsberger,
J. Strouboulis, and A. P. Wolffe.
1998.
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
Nat. Genet.
19:187-191[CrossRef][Medline].
|
| 31.
|
Kaludov, N. K., and A. P. Wolffe.
2000.
MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery.
Nucleic Acids Res.
28:1921-1928[Abstract/Free Full Text].
|
| 32.
|
Kass, S. U.,
J. P. Goddard, and R. L. Adams.
1993.
Inactive chromatin spreads from a focus of methylation.
Mol. Cell. Biol.
13:7372-7379[Abstract/Free Full Text].
|
| 33.
|
Lander, E. S.,
L. M. Linton,
B. Birren, et al.
2001.
Initial sequencing and analysis of the human genome.
Nature
409:860-921[CrossRef][Medline].
|
| 34.
|
Lewis, J. D.,
R. R. Meehan,
W. J. Henzel,
F. I. Maurer,
P. Jeppesen,
F. Klein, and A. Bird.
1992.
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.
Cell
69:905-914[CrossRef][Medline].
|
| 35.
|
Lorincz, M. C.,
D. Schübeler,
S. C. Goeke,
M. Walters,
M. Groudine, and D. I. Martin.
2000.
Dynamic analysis of proviral induction and de novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression.
Mol. Cell. Biol.
20:842-850[Abstract/Free Full Text].
|
| 36.
|
Magdinier, F., and A. P. Wolffe.
2001.
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Proc. Natl. Acad. Sci. USA
98:4990-4995[Abstract/Free Full Text].
|
| 37.
|
Nakayama, J.,
J. C. Rice,
B. D. Strahl,
C. D. Allis, and S. I. Grewal.
2001.
Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly.
Science
292:110-113[Abstract/Free Full Text].
|
| 38.
|
Nan, X.,
F. J. Campoy, and A. Bird.
1997.
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
Cell
88:471-481[CrossRef][Medline].
|
| 39.
|
Nan, X.,
H. H. Ng,
C. A. Johnson,
C. D. Laherty,
B. M. Turner,
R. N. Eisenman, and A. Bird.
1998.
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
Nature
393:386-389[CrossRef][Medline].
|
| 40.
|
Ng, H. H.,
Y. Zhang,
B. Hendrich,
C. A. Johnson,
B. M. Turner,
H. Erdjument-Bromage,
P. Tempst,
D. Reinberg, and A. Bird.
1999.
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.
Nat. Genet.
23:58-61[Medline].
|
| 41.
|
Orlando, V.,
H. Strutt, and R. Paro.
1997.
Analysis of chromatin structure by in vivo formaldehyde cross-linking.
Methods
11:205-214[CrossRef][Medline].
|
| 42.
|
Pazin, M. J., and J. T. Kadonaga.
1997.
What's up and down with histone deacetylation and transcription?
Cell
89:325-328[CrossRef][Medline].
|
| 43.
|
Reik, A.,
A. Telling,
G. Zitnik,
D. Cimbora,
E. Epner, and M. Groudine.
1998.
The locus control region is necessary for gene expression in the human beta-globin locus but not the maintenance of an open chromatin structure in erythroid cells.
Mol. Cell. Biol.
18:5992-6000[Abstract/Free Full Text].
|
| 44.
|
Schübeler, D.,
C. Francastel,
D. M. Cimbora,
A. Reik,
D. I. Martin, and M. Groudine.
2000.
Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human beta-globin locus.
Genes Dev.
14:940-950[Abstract/Free Full Text].
|
| 45.
|
Schübeler, D.,
M. C. Lorincz,
D. M. Cimbora,
A. Telling,
Y. Q. Feng,
E. E. Bouhassira, and M. Groudine.
2000.
Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation.
Mol. Cell. Biol.
20:9103-9112[Abstract/Free Full Text].
|
| 46.
|
Thompson, T., and H. Fan.
1985.
Mapping of DNase I-hypersensitive sites in the 5' and 3' long terminal repeats of integrated Moloney murine leukemia virus proviral DNA.
Mol. Cell. Biol.
5:601-609[Abstract/Free Full Text].
|
| 47.
|
Wade, P. A.,
A. Gegonne,
P. L. Jones,
E. Ballestar,
F. Aubry, and A. P. Wolffe.
1999.
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.
Nat. Genet.
23:62-66[Medline].
|
| 48.
|
Walsh, C. P.,
J. R. Chaillet, and T. H. Bestor.
1998.
Transcription of IAP endogenous retroviruses is constrained by cytosine methylation.
Nat. Genet.
20:116-117[CrossRef][Medline].
|
| 49.
|
Wan, M.,
K. Zhao,
S. S. Lee, and U. Francke.
2001.
MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
Hum. Mol. Genet.
10:1085-1092[Abstract/Free Full Text].
|
| 50.
|
Whitelaw, E., and D. I. Martin.
2001.
Retrotransposons as epigenetic mediators of phenotypic variation in mammals.
Nat. Genet.
27:361-365[CrossRef][Medline].
|
| 51.
|
Yu, F.,
J. Thiesen, and W. H. Stratling.
2000.
Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2.
Nucleic Acids Res.
28:2201-2206[Abstract/Free Full Text].
|
| 52.
|
Zhang, Y.,
H. H. Ng,
H. Erdjument-Bromage,
P. Tempst,
A. Bird, and D. Reinberg.
1999.
Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.
Genes Dev.
13:1924-1935[Abstract/Free Full Text].
|
| 53.
|
Zhu, B.,
D. Benjamin,
Y. Zheng,
H. Angliker,
S. Thiry,
M. Siegmann, and J. P. Jost.
2001.
Overexpression of 5-methylcytosine DNA glycosylase in human embryonic kidney cells EcR293 demethylates the promoter of a hormone-regulated reporter gene.
Proc. Natl. Acad. Sci. USA
98:5031-5036[Abstract/Free Full Text].
|
Molecular and Cellular Biology, December 2001, p. 7913-7922, Vol. 21, No. 23
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.23.7913-7922.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Burns, W. R., Zheng, Z., Rosenberg, S. A., Morgan, R. A.
(2009). Lack of specific {gamma}-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation. Blood
114: 2888-2899
[Abstract]
[Full Text]
-
Maksakova, I. A., Zhang, Y., Mager, D. L.
(2009). Preferential Epigenetic Suppression of the Autonomous MusD over the Nonautonomous ETn Mouse Retrotransposons. Mol. Cell. Biol.
29: 2456-2468
[Abstract]
[Full Text]
-
Garrison, B. S., Yant, S. R., Mikkelsen, J. G., Kay, M. A.
(2007). Postintegrative Gene Silencing within the Sleeping Beauty Transposition System. Mol. Cell. Biol.
27: 8824-8833
[Abstract]
[Full Text]
-
Yasui, D. H., Peddada, S., Bieda, M. C., Vallero, R. O., Hogart, A., Nagarajan, R. P., Thatcher, K. N., Farnham, P. J., LaSalle, J. M.
(2007). Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl. Acad. Sci. USA
104: 19416-19421
[Abstract]
[Full Text]
-
Katz, R. A., Jack-Scott, E., Narezkina, A., Palagin, I., Boimel, P., Kulkosky, J., Nicolas, E., Greger, J. G., Skalka, A. M.
(2007). High-Frequency Epigenetic Repression and Silencing of Retroviruses Can Be Antagonized by Histone Deacetylase Inhibitors and Transcriptional Activators, but Uniform Reactivation in Cell Clones Is Restricted by Additional Mechanisms. J. Virol.
81: 2592-2604
[Abstract]
[Full Text]
-
Ding, Y., Wang, X., Su, L., Zhai, J., Cao, S., Zhang, D., Liu, C., Bi, Y., Qian, Q., Cheng, Z., Chu, C., Cao, X.
(2007). SDG714, a Histone H3K9 Methyltransferase, Is Involved in Tos17 DNA Methylation and Transposition in Rice. Plant Cell
19: 9-22
[Abstract]
[Full Text]
-
Galvao, T. C., Thomas, J. O.
(2005). Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain. Nucleic Acids Res
33: 6603-6609
[Abstract]
[Full Text]
-
Fish, J. E., Matouk, C. C., Rachlis, A., Lin, S., Tai, S. C., D'Abreo, C., Marsden, P. A.
(2005). The Expression of Endothelial Nitric-oxide Synthase Is Controlled by a Cell-specific Histone Code. J. Biol. Chem.
280: 24824-24838
[Abstract]
[Full Text]
-
Tong, Y., Aune, T., Boothby, M.
(2005). T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-{gamma} promoter via a conserved T-box half-site. Proc. Natl. Acad. Sci. USA
102: 2034-2039
[Abstract]
[Full Text]
-
Escher, G., Hoang, A., Georges, S., Tchoua, U., El-Osta, A., Krozowski, Z., Sviridov, D.
(2005). Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages. J. Lipid Res.
46: 356-365
[Abstract]
[Full Text]
-
Kim, M., Trinh, B. N., Long, T. I., Oghamian, S., Laird, P. W.
(2004). Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells. Nucleic Acids Res
32: 5742-5749
[Abstract]
[Full Text]
-
Kriaucionis, S., Bird, A.
(2004). The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res
32: 1818-1823
[Abstract]
[Full Text]
-
DeMarco, R., Kowaltowski, A. T., Machado, A. A., Soares, M. B., Gargioni, C., Kawano, T., Rodrigues, V., Madeira, A. M. B. N., Wilson, R. A., Menck, C. F. M., Setubal, J. C., Dias-Neto, E., Leite, L. C. C., Verjovski-Almeida, S.
(2004). Saci-1, -2, and -3 and Perere, Four Novel Retrotransposons with High Transcriptional Activities from the Human Parasite Schistosoma mansoni. J. Virol.
78: 2967-2978
[Abstract]
[Full Text]
-
Swindle, C. S., Kim, H. G., Klug, C. A.
(2004). Mutation of CpGs in the Murine Stem Cell Virus Retroviral Vector Long Terminal Repeat Represses Silencing in Embryonic Stem Cells. J. Biol. Chem.
279: 34-41
[Abstract]
[Full Text]
-
Carvin, C. D., Parr, R. D., Kladde, M. P.
(2003). Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins. Nucleic Acids Res
31: 6493-6501
[Abstract]
[Full Text]
-
Yao, S., Osborne, C. S., Bharadwaj, R. R., Pasceri, P., Sukonnik, T., Pannell, D., Recillas-Targa, F., West, A. G., Ellis, J.
(2003). Retrovirus silencer blocking by the cHS4 insulator is CTCF independent. Nucleic Acids Res
31: 5317-5323
[Abstract]
[Full Text]
-
Zhao, X., Ueba, T., Christie, B. R., Barkho, B., McConnell, M. J., Nakashima, K., Lein, E. S., Eadie, B. D., Willhoite, A. R., Muotri, A. R., Summers, R. G., Chun, J., Lee, K.-F., Gage, F. H.
(2003). Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc. Natl. Acad. Sci. USA
100: 6777-6782
[Abstract]
[Full Text]
-
Chen, H., Toyooka, S., Gazdar, A. F., Hsieh, J.-T.
(2003). Epigenetic Regulation of a Novel Tumor Suppressor Gene (hDAB2IP) in Prostate Cancer Cell Lines. J. Biol. Chem.
278: 3121-3130
[Abstract]
[Full Text]
-
Ghoshal, K., Datta, J., Majumder, S., Bai, S., Dong, X., Parthun, M., Jacob, S. T.
(2002). Inhibitors of Histone Deacetylase and DNA Methyltransferase Synergistically Activate the Methylated Metallothionein I Promoter by Activating the Transcription Factor MTF-1 and Forming an Open Chromatin Structure. Mol. Cell. Biol.
22: 8302-8319
[Abstract]
[Full Text]
-
Lunyak, V. V., Burgess, R., Prefontaine, G. G., Nelson, C., Sze, S.-H., Chenoweth, J., Schwartz, P., Pevzner, P. A., Glass, C., Mandel, G., Rosenfeld, M. G.
(2002). Corepressor-Dependent Silencing of Chromosomal Regions Encoding Neuronal Genes. Science
298: 1747-1752
[Abstract]
[Full Text]
-
Lorincz, M. C., Schubeler, D., Hutchinson, S. R., Dickerson, D. R., Groudine, M.
(2002). DNA Methylation Density Influences the Stability of an Epigenetic Imprint and Dnmt3a/b-Independent De Novo Methylation. Mol. Cell. Biol.
22: 7572-7580
[Abstract]
[Full Text]
-
Koizume, S., Tachibana, K., Sekiya, T., Hirohashi, S., Shiraishi, M.
(2002). Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res
30: 4770-4780
[Abstract]
[Full Text]
-
Bane, T. K., LeBlanc, J. F., Lee, T. D., Riggs, A. D.
(2002). DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: effect of DNA methylation. Nucleic Acids Res
30: e69-e69
[Abstract]
[Full Text]
-
Suh, Y.-A., Lee, H.-Y., Virmani, A., Wong, J., Mann, K. K., Miller, W. H. Jr., Gazdar, A., Kurie, J. M.
(2002). Loss of Retinoic Acid Receptor {beta} Gene Expression Is Linked to Aberrant Histone H3 Acetylation in Lung Cancer Cell Lines. Cancer Res.
62: 3945-3949
[Abstract]
[Full Text]
-
El-Osta, A., Kantharidis, P., Zalcberg, J. R., Wolffe, A. P.
(2002). Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation. Mol. Cell. Biol.
22: 1844-1857
[Abstract]
[Full Text]